PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21268135-4	2011	In addition, pituitary tumor-transforming gene-1 (PTTG-1) protein and mRNA levels were also decreased in thyroid cancer cells treated with CDODA-Me or CF(3)DODA-Me and this was accompanied by decreased expression of PTTG-1-dependent c-Myc and fibroblast growth factor-2 (FGF-2) genes.	methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate	139-147	PTTG1 regulator of sister chromatid separation, securin	Homo sapiens	13-48	
21268135-4	2011	In addition, pituitary tumor-transforming gene-1 (PTTG-1) protein and mRNA levels were also decreased in thyroid cancer cells treated with CDODA-Me or CF(3)DODA-Me and this was accompanied by decreased expression of PTTG-1-dependent c-Myc and fibroblast growth factor-2 (FGF-2) genes.	methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate	139-147	PTTG1 regulator of sister chromatid separation, securin	Homo sapiens	50-56	
21268135-4	2011	In addition, pituitary tumor-transforming gene-1 (PTTG-1) protein and mRNA levels were also decreased in thyroid cancer cells treated with CDODA-Me or CF(3)DODA-Me and this was accompanied by decreased expression of PTTG-1-dependent c-Myc and fibroblast growth factor-2 (FGF-2) genes.	methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate	139-147	PTTG1 regulator of sister chromatid separation, securin	Homo sapiens	216-222	
21268135-6	2011	This study demonstrates for the first time that drugs, such as CDODA-Me and CF(3)DODA-Me, that decrease Sp protein expression also downregulate PTTG-1 in thyroid cancer cells and therefore have potential for clinical treatment of thyroid cancer and other endocrine neoplasias where PTTG-1 is a major pro-oncogenic factor.	methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate	63-71	PTTG1 regulator of sister chromatid separation, securin	Homo sapiens	144-150	
21268135-6	2011	This study demonstrates for the first time that drugs, such as CDODA-Me and CF(3)DODA-Me, that decrease Sp protein expression also downregulate PTTG-1 in thyroid cancer cells and therefore have potential for clinical treatment of thyroid cancer and other endocrine neoplasias where PTTG-1 is a major pro-oncogenic factor.	methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate	63-71	PTTG1 regulator of sister chromatid separation, securin	Homo sapiens	282-288